These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9811764)

  • 21. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.
    Yuan B; Campbell S; Bacharach E; Rein A; Goff SP
    J Virol; 2000 Aug; 74(16):7250-60. PubMed ID: 10906179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budding of retroviruses utilizing divergent L domains requires nucleocapsid.
    Bello NF; Dussupt V; Sette P; Rudd V; Nagashima K; Bibollet-Ruche F; Chen C; Montelaro RC; Hahn BH; Bouamr F
    J Virol; 2012 Apr; 86(8):4182-93. PubMed ID: 22345468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Demirov DG; Ono A; Orenstein JM; Freed EO
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Covalent conjugation of the equine infectious anemia virus Gag with SUMO.
    Wang J; Wen S; Zhao R; Qi J; Liu Z; Li W; An J; Wood C; Wang Y
    Biochem Biophys Res Commun; 2017 May; 486(3):712-719. PubMed ID: 28342872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of feline immunodeficiency virus budding.
    Luttge BG; Shehu-Xhilaga M; Demirov DG; Adamson CS; Soheilian F; Nagashima K; Stephen AG; Fisher RJ; Freed EO
    J Virol; 2008 Mar; 82(5):2106-19. PubMed ID: 18094166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of gag multimers with filamentous actin during equine infectious anemia virus assembly.
    Chen C; Jin J; Rubin M; Huang L; Sturgeon T; Weixel KM; Stolz DB; Watkins SC; Bamburg JR; Weisz OA; Montelaro RC
    Curr HIV Res; 2007 May; 5(3):315-23. PubMed ID: 17504173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional replacement of a retroviral late domain by ubiquitin fusion.
    Joshi A; Munshi U; Ablan SD; Nagashima K; Freed EO
    Traffic; 2008 Nov; 9(11):1972-83. PubMed ID: 18817521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
    Ott DE; Coren LV; Gagliardi TD; Nagashima K
    J Virol; 2005 Jul; 79(14):9038-45. PubMed ID: 15994797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
    Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
    J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
    Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM
    J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of retroviral late domains as determinants of particle size.
    Garnier L; Parent LJ; Rovinski B; Cao SX; Wills JW
    J Virol; 1999 Mar; 73(3):2309-20. PubMed ID: 9971814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solution structure of the human immunodeficiency virus type 1 p6 protein.
    Fossen T; Wray V; Bruns K; Rachmat J; Henklein P; Tessmer U; Maczurek A; Klinger P; Schubert U
    J Biol Chem; 2005 Dec; 280(52):42515-27. PubMed ID: 16234236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equine infectious anemia virus and the ubiquitin-proteasome system.
    Ott DE; Coren LV; Sowder RC; Adams J; Nagashima K; Schubert U
    J Virol; 2002 Mar; 76(6):3038-44. PubMed ID: 11861870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected].
    Bouamr F; Melillo JA; Wang MQ; Nagashima K; de Los Santos M; Rein A; Goff SP
    J Virol; 2003 Nov; 77(22):11882-95. PubMed ID: 14581525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of equine infectious anemia virus matrix protein.
    Hatanaka H; Iourin O; Rao Z; Fry E; Kingsman A; Stuart DI
    J Virol; 2002 Feb; 76(4):1876-83. PubMed ID: 11799182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.
    Patnaik A; Wills JW
    J Virol; 2002 Mar; 76(6):2789-95. PubMed ID: 11861846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
    Zhang W; Lonning SM; McGuire TC
    J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
    Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
    Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter.
    Carvalho M; Derse D
    J Virol; 1993 Apr; 67(4):2064-74. PubMed ID: 8383228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ESCRT requirements for EIAV budding.
    Sandrin V; Sundquist WI
    Retrovirology; 2013 Oct; 10():104. PubMed ID: 24107264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.